Park, Chong-Woo, et al. “The Safety Evaluation of FM101, an A3 Adenosine Receptor Modulator, in Rat, for Developing As Therapeutics of Glaucoma and Hepatitis”. EXCLI Journal, vol. 19, Feb. 2020, pp. 187-00, doi:10.17179/excli2019-2058.